Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder

NCT00796614 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

231

Enrollment

INDUSTRY

Sponsor class

Conditions

Bladder, Neurogenic

Interventions

DRUG: tamsulosin hydrochloride
DRUG: Placebo

Sponsor

Boehringer Ingelheim